REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 31 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,437,600 | -35.5% | 3,047,000 | -15.3% | 0.00% | – |
| Q2 2023 | $3,776,850 | -17.6% | 3,597,000 | -3.7% | 0.00% | – |
| Q1 2023 | $4,582,204 | +29.7% | 3,736,000 | -3.5% | 0.00% | – |
| Q4 2022 | $3,534,223 | -3.0% | 3,871,000 | +14.8% | 0.00% | – |
| Q3 2022 | $3,645,000 | -14.7% | 3,371,000 | -37.4% | 0.00% | -100.0% |
| Q2 2022 | $4,274,000 | +7.6% | 5,388,000 | +28.0% | 0.00% | 0.0% |
| Q1 2022 | $3,972,000 | +7.6% | 4,208,000 | 0.0% | 0.00% | – |
| Q4 2021 | $3,692,000 | -22.2% | 4,208,000 | +1.8% | 0.00% | -100.0% |
| Q3 2021 | $4,745,000 | -43.2% | 4,133,000 | -42.2% | 0.00% | 0.0% |
| Q2 2021 | $8,351,000 | -9.5% | 7,152,000 | -13.1% | 0.00% | 0.0% |
| Q1 2021 | $9,224,000 | – | 8,232,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 20,087 | $23,535,000 | 2.18% |
| ZAZOVE ASSOCIATES LLC | 15,910,000 | $18,551,000 | 1.66% |
| SSI INVESTMENT MANAGEMENT LLC | 4,487,000 | $5,231,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,918,000 | $5,752,000 | 0.17% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 3,000,000 | $3,500,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 12,500,000 | $14,646,000 | 0.03% |
| Citadel Advisors | 104,329,000 | $122,081,000 | 0.03% |
| LAZARD ASSET MANAGEMENT LLC | 20,000,000 | $23,433,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 2,918,000 | $3,416,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $56,240,000 | 0.02% |